Leucine and HMB Differentially Modulate Proteasome System in Skeletal Muscle Under Different Sarcopenic Conditions

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Oct 15

PMID 24124592

Citations 18

Authors

Igor L Baptista

Willian J Silva

Guilherme G Artioli

Joao Paulo L F Guilherme

Marcelo L Leal

Marcelo S Aoki

Elen H Miyabara

Anselmo S Moriscot

Affiliations

Soon will be listed here.

Abstract

In the present study we have compared the effects of leucine supplementation and its metabolite β-hydroxy-β-methyl butyrate (HMB) on the ubiquitin-proteasome system and the PI3K/Akt pathway during two distinct atrophic conditions, hindlimb immobilization and dexamethasone treatment. Leucine supplementation was able to minimize the reduction in rat soleus mass driven by immobilization. On the other hand, leucine supplementation was unable to provide protection against soleus mass loss in dexamethasone treated rats. Interestingly, HMB supplementation was unable to provide protection against mass loss in all treatments. While solely fiber type I cross sectional area (CSA) was protected in immobilized soleus of leucine-supplemented rats, none of the fiber types were protected by leucine supplementation in rats under dexamethasone treatment. In addition and in line with muscle mass results, HMB treatment did not attenuate CSA decrease in all fiber types against either immobilization or dexamethasone treatment. While leucine supplementation was able to minimize increased expression of both Mafbx/Atrogin and MuRF1 in immobilized rats, leucine was only able to minimize Mafbx/Atrogin in dexamethasone treated rats. In contrast, HMB was unable to restrain the increase in those atrogenes in immobilized rats, but in dexamethasone treated rats, HMB minimized increased expression of Mafbx/Atrogin. The amount of ubiquitinated proteins, as expected, was increased in immobilized and dexamethasone treated rats and only leucine was able to block this increase in immobilized rats but not in dexamethasone treated rats. Leucine supplementation maintained soleus tetanic peak force in immobilized rats at normal level. On the other hand, HMB treatment failed to maintain tetanic peak force regardless of treatment. The present data suggested that the anti-atrophic effects of leucine are not mediated by its metabolite HMB.

Citing Articles

Superior bioavailability of the calcium salt form of β-hydroxy-β-methylbutyrate compared with the free acid form.

Ribeiro H, Jardim F, Roldan M, de Salles Painelli V, da Eira Silva V, Tritto A Amino Acids. 2024; 56(1):27.

PMID: 38564019 PMC: 10987370. DOI: 10.1007/s00726-023-03369-z.

ß-Hydroxy-ß-methylbutyrate: A feed supplement influencing performance, bone metabolism, intestinal morphology, and muscle quality of laying hens: a preliminary one-point study.

Tomaszewska E, Swiatkiewicz S, Arczewska-Wlosek A, Wojtysiak D, Dobrowolski P, Domaradzki P Poult Sci. 2024; 103(5):103597.

PMID: 38471225 PMC: 11067770. DOI: 10.1016/j.psj.2024.103597.

Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition.

Alves P, Schauer A, Augstein A, Mannel A, Barthel P, Joachim D Cells. 2023; 12(21).

PMID: 37947639 PMC: 10648219. DOI: 10.3390/cells12212561.

Sarcopenia in chronic kidney disease: from bench to bedside.

Kim D, Song S Korean J Intern Med. 2023; 38(3):303-321.

PMID: 37077132 PMC: 10175867. DOI: 10.3904/kjim.2022.338.

Gene Expression Profile Provides Novel Insights of Fasting-Refeeding Response in Zebrafish Skeletal Muscle.

Sugasawa T, Komine R, Manevich L, Tamai S, Takekoshi K, Kanki Y Nutrients. 2022; 14(11).

PMID: 35684038 PMC: 9182819. DOI: 10.3390/nu14112239.

References

Zanchi N, Gerlinger-Romero F, Guimaraes-Ferreira L, de Siqueira Filho M, Felitti V, Lira F . HMB supplementation: clinical and athletic performance-related effects and mechanisms of action. Amino Acids. 2010; 40(4):1015-25. DOI: 10.1007/s00726-010-0678-0. View

Booth F . Effect of limb immobilization on skeletal muscle. J Appl Physiol Respir Environ Exerc Physiol. 1982; 52(5):1113-8. DOI: 10.1152/jappl.1982.52.5.1113. View

Wray C, Mammen J, Hershko D, Hasselgren P . Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol. 2003; 35(5):698-705. DOI: 10.1016/s1357-2725(02)00341-2. View

Sugawara T, Ito Y, Nishizawa N, Nagasawa T . Supplementation with dietary leucine to a protein-deficient diet suppresses myofibrillar protein degradation in rats. J Nutr Sci Vitaminol (Tokyo). 2008; 53(6):552-5. DOI: 10.3177/jnsv.53.552. View

Garcia Soares A, Aoki M, Miyabara E, Deluca C, Ono H, Gomes M . Ubiquitin-ligase and deubiquitinating gene expression in stretched rat skeletal muscle. Muscle Nerve. 2007; 36(5):685-93. DOI: 10.1002/mus.20866. View

Clarke B, Drujan D, Willis M, Murphy L, Corpina R, Burova E . The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab. 2007; 6(5):376-85. DOI: 10.1016/j.cmet.2007.09.009. View

Zhang P, Chen X, Fan M . Signaling mechanisms involved in disuse muscle atrophy. Med Hypotheses. 2007; 69(2):310-21. DOI: 10.1016/j.mehy.2006.11.043. View

Gustafsson T, Osterlund T, Flanagan J, von Walden F, Trappe T, Linnehan R . Effects of 3 days unloading on molecular regulators of muscle size in humans. J Appl Physiol (1985). 2010; 109(3):721-7. DOI: 10.1152/japplphysiol.00110.2009. View

Baracos V, DEVIVO C, Hoyle D, GOLDBERG A . Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol. 1995; 268(5 Pt 1):E996-1006. DOI: 10.1152/ajpendo.1995.268.5.E996. View

10.

Kayali A, Young V, Goodman M . Sensitivity of myofibrillar proteins to glucocorticoid-induced muscle proteolysis. Am J Physiol. 1987; 252(5 Pt 1):E621-6. DOI: 10.1152/ajpendo.1987.252.5.E621. View

11.

Vary T, Anthony J, Jefferson L, Kimball S, Lynch C . Rapamycin blunts nutrient stimulation of eIF4G, but not PKCepsilon phosphorylation, in skeletal muscle. Am J Physiol Endocrinol Metab. 2007; 293(1):E188-96. DOI: 10.1152/ajpendo.00037.2007. View

12.

Stipanuk M . Leucine and protein synthesis: mTOR and beyond. Nutr Rev. 2007; 65(3):122-9. DOI: 10.1111/j.1753-4887.2007.tb00289.x. View

13.

Kandarian S, Jackman R . Intracellular signaling during skeletal muscle atrophy. Muscle Nerve. 2005; 33(2):155-65. DOI: 10.1002/mus.20442. View

14.

Gomes M, Lecker S, Jagoe R, Navon A, GOLDBERG A . Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A. 2001; 98(25):14440-5. PMC: 64700. DOI: 10.1073/pnas.251541198. View

15.

Hao Y, Jackson J, Wang Y, Edens N, Pereira S, Alway S . β-Hydroxy-β-methylbutyrate reduces myonuclear apoptosis during recovery from hind limb suspension-induced muscle fiber atrophy in aged rats. Am J Physiol Regul Integr Comp Physiol. 2011; 301(3):R701-15. PMC: 3174754. DOI: 10.1152/ajpregu.00840.2010. View

16.

Sugawara T, Ito Y, Nishizawa N, Nagasawa T . Regulation of muscle protein degradation, not synthesis, by dietary leucine in rats fed a protein-deficient diet. Amino Acids. 2008; 37(4):609-16. DOI: 10.1007/s00726-008-0180-0. View

17.

Mammucari C, Schiaffino S, Sandri M . Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle. Autophagy. 2008; 4(4):524-6. DOI: 10.4161/auto.5905. View

18.

Haegens A, Schols A, Gorissen S, van Essen A, Snepvangers F, Gray D . NF-κB activation and polyubiquitin conjugation are required for pulmonary inflammation-induced diaphragm atrophy. Am J Physiol Lung Cell Mol Physiol. 2011; 302(1):L103-10. DOI: 10.1152/ajplung.00084.2011. View

19.

Anthony J, Anthony T, Kimball S, Jefferson L . Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J Nutr. 2001; 131(3):856S-860S. DOI: 10.1093/jn/131.3.856S. View

20.

Smith H, Mukerji P, Tisdale M . Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss. Cancer Res. 2005; 65(1):277-83. View